Abstract:Editorial Office Annals of Translational Medicine Submitted Mar 06, 2024. Accepted for publication Mar 13, 2024. Published online Jun 13, 2024. doi: 10.21037/atm-2024-4 Erratum to: Ann Transl Med 2021;9:1556. This article (1) titled "Preoperative prediction of gastrointestinal stromal tumors with high Ki-67 proliferation index based on CT features" (doi: 10.21037/atm-21-4669) unfortunately contains an error in the first author's affiliation. The original affiliation 1 should not be added to the first author. Following this change, the original affiliation 2 should be changed to affiliation 1, and the original affiliation 1 should be changed to affiliation 2. The rest remains unchanged. The updated authorship section is as follows: Cai-Wei Yang 1# ^, Xi-Jiao Liu 1# ^, Lian Zhao 1 ^, Feng Che 2 ^, Yuan Yin 3 ^, Hui-Jiao Chen 4 ^, Bo Zhang 3 ^, Min Wu 5,6,7 ^, Bin Song 1 ^ 1 Department of Radiology, West China Hospital, Sichuan University, Chengdu, China; 2 West China School of Medicine, Sichuan University, Chengdu, China; 3 Department of Gastrointestinal Surgery, West China Hospital, Sichuan University, Chengdu, China; 4 Department of Pathology, West China Hospital, Sichuan University, Chengdu, China; 5 Huaxi MR Research Center (HMRRC), Department of Radiology, West China Hospital, Sichuan University, Chengdu, China; 6 Department of Clinic Medical Center, Dazhou Central Hospital, Dazhou, China; 7 Department of Radiology, Molecular Imaging Program at Stanford (MIPS), Stanford University, Stanford, CA, USA The authors apologize for the oversight. Click here to view the updated version of the article. Open Access Statement: This is an Open Access article distributed in accordance with the Creative Commons Attribution-NonCommercial-NoDerivs 4.0 International License (CC BY-NC-ND 4.0), which permits the non-commercial replication and distribution of the article with the strict proviso that no changes or edits are made and the original work is properly cited (including links to both the formal publication through the relevant DOI and the license). See: https://creativecommons.org/licenses/by-nc-nd/4.0/.

Pathologic Stage of Nonsmall Cell Lung Cancer Patients Presenting as Resectable Cases After Neoadjuvant Therapy Did Not Predict the Prognosis: Erratum

Benefit of Primary Tumor Resection in Stage IV, Grade 1 and 2, Pancreatic Neuroendocrine Tumors: A Propensity-Score Matched Cohort Study: Erratum

Erratum to maintaining excellent outcomes: the impact of age cutoff reclassification on reduced therapy for neuroblastoma patients

Erratum to "Additional biomarkers for pathological complete response in triple negative breast cancer"

Corrigendum to "re: Pathologic Complete Responses, Long-Term Outcomes, and Recurrence Patterns in HER2-low Vs. HER2-zero Breast Cancer after Neoadjuvant Chemotherapy: Several Issues about HER2 Expression and Neoadjuvant Chemotherapy in Breast Cancer" [eur J Cancer 180 (2023) 184-185].

Correction To: Early Presence of Anti-Angiogenesis-related Adverse Events As a Potential Biomarker of Antitumor Efficacy in Metastatic Gastric Cancer Patients Treated with Apatinib: a Cohort Study

Intraoperative Prediction of Non-Sentinel Lymph Node Metastasis Based on the Molecular Assay in Breast Cancer Patients [Corrigendum]

Erratum: Spread Through Air Spaces Predicts a Worse Survival in Patients with Stage I Adenocarcinomas >2 Cm after Radical Lobectomy.

Correction To: the Impact of Right Ventricular Function on Prognosis in Patients with Stage III Non-Small Cell Lung Cancer after Concurrent Chemoradiotherapy

Baseline Serum Cholesterol Levels Predict the Response of Patients with Advanced Non-Small Cell Lung Cancer to Immune Checkpoint Inhibitor-Based Treatment [Corrigendum]

Erratum to preoperative prediction of gastrointestinal stromal tumors with high Ki-67 proliferation index based on CT features

Erratum: Investigating tumor immunogenicity in breast cancer: deciphering the tumor immune response to enhance therapeutic approaches

Modification of N Staging Systems for Penile Cancer: a More Precise Prediction of Prognosis

ERRATUM: Correction of the Conflict of Interest. Difference in prognostic impact of lateral pelvic lymph node metastasis between pre- and post-neoadjuvant chemoradiotherapy in rectal cancer patients

Erratum: Novel permissive murine immunocompetent orthotopic colon carcinoma model for comparison of the antitumoral and safety profiles of three Adv-TKs

Erratum: Preoperative immunological plasma markers TRAIL, CSF1, and TIE2 predict survival after resection for biliary tract cancer

Erratum: Mutational Landscape of Metastatic Cancer Revealed from Prospective Clinical Sequencing of 10,000 Patients

Erratum: Prognostic Effect of Sarcopenia in Hepatocellular Carcinoma Patients Targeted with Interventional Therapy Combined with Immunotherapy and Targeted Therapy [Corrigendum]

Erratum: Recombinant Mutated Human TNF in Combination with Chemotherapy for Stage IIIB/IV Non-Small Cell Lung Cancer: A Randomized, Phase III Study.

Erratum: SPAG5 upregulation predicts poor prognosis in cervical cancer patients and alters sensitivity to taxol treatment via the mTOR signaling pathway

Retracted: Prognosis and Therapeutic Efficacy Prediction of Adrenocortical Carcinoma Based on a Necroptosis-Associated Gene Signature